Ferrier ( 2011 ) Lippincotts Illustrated Reviews: Biochemistry Fifth Edition Philadelphia, PA, page 191 3-)Rebouche CJ
Who should avoid using Semaglutide
Clinically, that 5% mark is meaningful: its commonly used as a benchmark for whether a medication is providing benefit, not as a final outcome
In particular, preclinical studies have demonstrated that GLP-1 and its more stable and long-lasting analogues GLP-1RAs possess neuroprotective and antiapoptotic properties, modulate long-term potentiation and synaptic plasticity, as well as promote the differentiation of neuron precursors, and can reduce depressive behavior [75]
Additionally, the lower risk of blood vessel puncture and fewer nerve endings in the subcutaneous tissue in these areas make it a safe and effective option for peptide therapy [2]
One of the newest options available to women is Semaglutide, a medication originally designed for diabetes management that is now gaining attention for its potential benefits in supporting women through menopause